UA107920C2 - Substituted pyrimidine for the treatment of diseases such as cancer - Google Patents
Substituted pyrimidine for the treatment of diseases such as cancerInfo
- Publication number
- UA107920C2 UA107920C2 UAA201107743A UAA201107743A UA107920C2 UA 107920 C2 UA107920 C2 UA 107920C2 UA A201107743 A UAA201107743 A UA A201107743A UA A201107743 A UAA201107743 A UA A201107743A UA 107920 C2 UA107920 C2 UA 107920C2
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- diseases
- cancer
- substituted pyrimidine
- paragraph
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
У заявці описані сполуки загальної формули (1), (1)в якій значення А, В, X, R-Rвизначені у пункті 1 формули винаходу, які можуть бути застосовані для лікування захворювань, які характеризуються надмірною або аномальною проліферацією клітин, і їх застосування для приготування лікарського засобу, який має зазначені вище характеристики.The application describes compounds of General formula (1), (1) in which the values of A, B, X, R-R are defined in paragraph 1 of the claims, which can be used for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use for the preparation of a medicinal product having the above characteristics.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08169807 | 2008-11-24 | ||
PCT/EP2009/065768 WO2010058032A2 (en) | 2008-11-24 | 2009-11-24 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
UA107920C2 true UA107920C2 (en) | 2015-03-10 |
Family
ID=40612944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201107743A UA107920C2 (en) | 2008-11-24 | 2009-11-24 | Substituted pyrimidine for the treatment of diseases such as cancer |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA107920C2 (en) |
-
2009
- 2009-11-24 UA UAA201107743A patent/UA107920C2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201100794A1 (en) | SUBSTITUTED PYRIMIDINES INTENDED FOR THE TREATMENT OF DISEASES, SUCH AS CANCER | |
MA33939B1 (en) | 5-alkynyl-PYRIMIDINE | |
EA201201661A1 (en) | NEW AMINOPYRAZOLOHINAZOLINES | |
EA201101330A1 (en) | SUBSTITUTED PYRIMIDINES INTENDED FOR CANCER TREATMENT | |
EA201000105A1 (en) | CHEMICAL COMPOUNDS | |
EA201100564A1 (en) | ANTIPROLIFERATIVE COMPOUNDS | |
MX343706B (en) | Novel heterocyclic derivatives. | |
MX2013001970A (en) | Pyrrolopyrimidine compounds and uses thereof. | |
EA201500536A1 (en) | TRIAZOLOPIRAZIN | |
MX2013004491A (en) | Boronates as arginase inhibitors. | |
EA201100255A1 (en) | 5-Alkinylpyrimidines | |
EA201490493A1 (en) | PIRANO [3,2-D] [1,3] TIAZOLE AS GLYOZIDASE INHIBITORS | |
MX2012013274A (en) | Novel pyrimidine derivatives. | |
EA201100254A1 (en) | NEW CONNECTIONS | |
MX2011012643A (en) | 2, 4 -diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation. | |
MY151342A (en) | Phenylamino isonicotinamide compounds | |
WO2015042414A8 (en) | Multicyclic compounds and methods of using same | |
EA201001427A1 (en) | TIAZOLIDIGIDROIDAZOLE | |
TN2011000531A1 (en) | 5- alkynyl - pyridines | |
WO2009151495A3 (en) | Oxazole compounds, compositions and methods of use | |
EA201101537A1 (en) | TIATRIASOCYCLOPENTAZULARS AS PI3-KINAZ INHIBITORS INTENDED FOR CANCER TREATMENT | |
TN2012000370A1 (en) | 5-alkynyl pyrimidines and their use as kinase inhibitors | |
UA107920C2 (en) | Substituted pyrimidine for the treatment of diseases such as cancer | |
TN2013000327A1 (en) | Novel heterocyclic derivatives | |
TN2013000012A1 (en) | New aminopyrazoloquinazolines |